Oxazinanes

Organic heterocyclic compounds that consist of a six-membered ring that has four carbon atoms, one nitrogen atom, and one oxygen atom.

Search Within Results

2,266 – 2,280 of 2,960 results

2,266

eMolecules 132073-83-7 | (S)-Morpholin-2-ylmethanol | Ambeed | MFCD09260718 | 117.148 | C5H11NO2 | 95.000 | OC[C@@H]1CNCCO1 | 100mg | 628568384

(S)-Morpholin-2-ylmethanol | Ambeed | 132073-83-7 | MFCD09260718 | 117.148 | C5H11NO2 | 95.000 | OC[C@@H]1CNCCO1 | 100mg | 628568384

Pricing & Availability

2,267

eMolecules 365215-38-9 | (R,R)-Bn-Pybox | ChemScene | MFCD23704922 | 397.478 | C25H23N3O2 | 95.000 | C([C@@H]1COC(=N1)c1cccc(n1)C1=N[C@H](Cc2ccccc2)CO1)c1ccccc1 | 250mg | 536799838

(R,R)-Bn-Pybox | ChemScene | 365215-38-9 | MFCD23704922 | 397.478 | C25H23N3O2 | 95.000 | C([C@@H]1COC(=N1)c1cccc(n1)C1=N[C@H](Cc2ccccc2)CO1)c1ccccc1 | 250mg | 536799838

Pricing & Availability

2,268

eMolecules 6-BROMO-3 4-DIHYDRO-2H-ISOQ 5G

5000166027 6-BROMO-3 4-DIHYDRO-2H-ISOQ 5G

Pricing & Availability

2,269

eMolecules 1225376-02-2 | (R)-2-PHENYLMORPHOLINE | AstaTech | MFCD18249849 | 163.220 | C10H13NO | 95.000 | C1CO[C@@H](CN1)c1ccccc1 | 0.25g | 302799645

(R)-2-PHENYLMORPHOLINE | AstaTech | 1225376-02-2 | MFCD18249849 | 163.220 | C10H13NO | 95.000 | C1CO[C@@H](CN1)c1ccccc1 | 0.25g | 302799645

Pricing & Availability

2,270

eMolecules 132073-83-7 | (S)-MORPHOLIN-2-YLMETHANOL | AstaTech | MFCD09260718 | 117.148 | C5H11NO2 | 95.000 | OC[C@@H]1CNCCO1 | 0.25g | 449764028

(S)-MORPHOLIN-2-YLMETHANOL | AstaTech | 132073-83-7 | MFCD09260718 | 117.148 | C5H11NO2 | 95.000 | OC[C@@H]1CNCCO1 | 0.25g | 449764028

Pricing & Availability

2,271

eMolecules 7-HYDROXY-2 3-DIHYDRO-1H-I 10G

5000188658 7-HYDROXY-2 3-DIHYDRO-1H-I 10G

Pricing & Availability

2,272

eMolecules 628732-09-2 | Methyl 5-bromo-2,3-dihydro-1H-indene-2-carboxylate | Combi-Blocks, Inc. | MFCD17926572 | 255.111 | C11H11BrO2 | 96.000 | COC(=O)C1Cc2ccc(Br)cc2C1 | 1g | 586078642

Methyl 5-bromo-2,3-dihydro-1H-indene-2-carboxylate | Combi-Blocks, Inc. | 628732-09-2 | MFCD17926572 | 255.111 | C11H11BrO2 | 96.000 | COC(=O)C1Cc2ccc(Br)cc2C1 | 1g | 586078642

Pricing & Availability

2,273

eMolecules 286-22-6 | 3,7-Dioxabicyclo[4.1.0]heptane | Apollo Scientific | MFCD11226853 | 100.117 | C5H8O2 | 95.000 | C1CC2OC2CO1 | 250mg | 600856286

3,7-Dioxabicyclo[4.1.0]heptane | Apollo Scientific | 286-22-6 | MFCD11226853 | 100.117 | C5H8O2 | 95.000 | C1CC2OC2CO1 | 250mg | 600856286

Pricing & Availability

2,274

eMolecules 163105-90-6 | 2-Methoxypyridine-3-boronic acid | Apollo Scientific US - Building Blocks | MFCD03411572 | 152.940 | C6H8BNO3 | 95.000 | COc1ncccc1B(O)O | 25g | 404236726

2-Methoxypyridine-3-boronic acid | Apollo Scientific US - Building Blocks | 163105-90-6 | MFCD03411572 | 152.940 | C6H8BNO3 | 95.000 | COc1ncccc1B(O)O | 25g | 404236726

Pricing & Availability

2,275

eMolecules 1149-23-1 | Diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate | Combi-Blocks | MFCD00005951 | 253.298 | C13H19NO4 | 95.000 | CCOC(=O)C1=C(C)NC(C)=C(C1)C(=O)OCC | 1kg | 342861727

Diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate | Combi-Blocks | 1149-23-1 | MFCD00005951 | 253.298 | C13H19NO4 | 95.000 | CCOC(=O)C1=C(C)NC(C)=C(C1)C(=O)OCC | 1kg | 342861727

Pricing & Availability

2,276

eMolecules 212127-80-5 | 2-(2,5-Dihydro-3-furanyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | Synthonix - Stock | MFCD16996209 | 196.050 | C10H17BO3 | 95.000 | CC1(C)OB(OC1(C)C)C1=CCOC1 | 250mg | 525914654

2-(2,5-Dihydro-3-furanyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | Synthonix - Stock | 212127-80-5 | MFCD16996209 | 196.050 | C10H17BO3 | 95.000 | CC1(C)OB(OC1(C)C)C1=CCOC1 | 250mg | 525914654

Pricing & Availability

2,277

Apexbio Technology LLC PI-103 Hydrochloride 371935-79-4 10mM (in 1mL DMSO)

PI-103 Hydrochloride (CAS 371935-79-4) is a dual inhibitor targeting class I phosphatidylinositide 3-kinases (PI3K) and mammalian target of rapamycin (mTOR) It selectively inhibits PI3K isoforms p110 p110 p110 and mTOR with reported IC50 values of 0 002 M 0 003 M 0 003 M and 0 030 M respectively PI-103 effectively blocks the PI3K/Akt/mTOR pathway which is centrally involved in cell proliferation and survival signaling and is frequently dysregulated in cancer In various cellular models including leukemia hepatocellular carcinoma glioblastoma and neuroblastoma PI-103 suppresses pathway activation and inhibits cell proliferation It is widely used for investigating PI3K/Akt/mTOR signaling in oncology research

Pricing & Availability

2,278

eMolecules 5S-5 6-DIHYDRO-5-1-ME 100MG

5000191969 5S-5 6-DIHYDRO-5-1-ME 100MG

Pricing & Availability

2,279

eMolecules Combi-Blocks 2-(Morpholin-4-yl)-8-phenylchromen-4-one 250mg 517114403 QI-9914 95 000 154447-36-6 MFCD00270881 307 349 C19H17NO3

Combi-Blocks 2-(Morpholin-4-yl)-8-phenylchromen-4-one 250mg 517114403 QI-9914 95 000 154447-36-6 MFCD00270881 307 349 C19H17NO3

Pricing & Availability

2,280

eMolecules 1149-23-1 | Diethyl 1,4-Dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate | Accela ChemBio (ASD) | MFCD00005951 | 253.298 | C13H19NO4 | 95.000 | CCOC(=O)C1=C(C)NC(C)=C(C1)C(=O)OCC | 10g | 533771351

Diethyl 1,4-Dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate | Accela ChemBio (ASD) | 1149-23-1 | MFCD00005951 | 253.298 | C13H19NO4 | 95.000 | CCOC(=O)C1=C(C)NC(C)=C(C1)C(=O)OCC | 10g | 533771351

Pricing & Availability

Oxazinanes

Filtered Search Results

Narrow Results